Evidence map›Paper›PMID 36982250›Full record

ArticleInternational journal of molecular sciences2023

Evan M Holbrook, Cristian A Zambrano, Caelan T O Wright, Elizabeth M Dubé, Jessica R Stewart, William J Sanders, Matthew G Frank, Andrew S MacDonald, Stefan O Reber, Christopher A Lowry

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Effects ofInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Evan M HolbrookDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA.
Cristian A ZambranoDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA.
Caelan T O WrightDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, CO 80309, USA.
Elizabeth M DubéDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80309, USA.ORCID 0009-0006-9166-4583
Jessica R StewartDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80309, USA.
William J SandersDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, CO 80309, USA.
Matthew G FrankDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80309, USA.ORCID 0000-0001-8613-6897
Andrew S MacDonaldLydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester M13 9NT, UK.
Stefan O ReberLaboratory for Molecular Psychosomatics, Department of Psychosomatic Medicine and Psychotherapy, Ulm University Medical Center, 89081 Ulm, Germany.ORCID 0000-0002-1583-7618
Christopher A LowryDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA.ORCID 0000-0003-3920-5575
University of Colorado Boulder · USUniversity of Manchester · GB

Funding

Benefunder Anonymous donor
6 · The paper itself

Abstract

Inflammatory conditions, including allergic asthma and conditions in which chronic low-grade inflammation is a risk factor, such as stress-related psychiatric disorders, are prevalent and are a significant cause of disability worldwide. Novel approaches for the prevention and treatment of these disorders are needed. One approach is the use of immunoregulatory microorganisms, such as

Indexed as

LipopolysaccharidesMycobacteriumHumansInflammationMacrophagesMycobacteriaceaeNeuroinflammatory DiseasesLipopolysaccharidesIL-10IL-12IL-23immunoregulationmacrophagemonocyteMycobacterium vaccaereal-time RT-PCRTGF-β1THP-1

Identifiers

PMID36982250
PMCPMC10049321
OpenAlexW4323568654

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read61
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.